265 related articles for article (PubMed ID: 16517208)
1. Sickle cell disease and nitric oxide: a paradigm shift?
Mack AK; Kato GJ
Int J Biochem Cell Biol; 2006; 38(8):1237-43. PubMed ID: 16517208
[TBL] [Abstract][Full Text] [Related]
2. Sickle cell anemia and vascular dysfunction: the nitric oxide connection.
Akinsheye I; Klings ES
J Cell Physiol; 2010 Sep; 224(3):620-5. PubMed ID: 20578237
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide pathology and therapeutics in sickle cell disease.
Kim-Shapiro DB; Gladwin MT
Clin Hemorheol Microcirc; 2018; 68(2-3):223-237. PubMed ID: 29614634
[TBL] [Abstract][Full Text] [Related]
4. Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
Wood KC; Granger DN
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):926-32. PubMed ID: 17645642
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide transport on sickle cell hemoglobin: where does it bind?
Gladwin MT; Ognibene FP; Shelhamer JH; Pease-Fye ME; Noguchi CT; Rodgers GP; Schechter AN
Free Radic Res; 2001 Aug; 35(2):175-80. PubMed ID: 11697198
[TBL] [Abstract][Full Text] [Related]
6. The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology.
Krajewski ML; Hsu LL; Gladwin MT
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H4-7. PubMed ID: 18502905
[No Abstract] [Full Text] [Related]
7. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.
Reiter CD; Wang X; Tanus-Santos JE; Hogg N; Cannon RO; Schechter AN; Gladwin MT
Nat Med; 2002 Dec; 8(12):1383-9. PubMed ID: 12426562
[TBL] [Abstract][Full Text] [Related]
8. Redox-dependent impairment of vascular function in sickle cell disease.
Aslan M; Freeman BA
Free Radic Biol Med; 2007 Dec; 43(11):1469-83. PubMed ID: 17964418
[TBL] [Abstract][Full Text] [Related]
9. Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.
Kaul DK; Liu XD; Chang HY; Nagel RL; Fabry ME
J Clin Invest; 2004 Oct; 114(8):1136-45. PubMed ID: 15489961
[TBL] [Abstract][Full Text] [Related]
10. Can we just say NO to sickle cell anemia?
Nagel RL
J Clin Invest; 1999 Oct; 104(7):847-8. PubMed ID: 10510323
[No Abstract] [Full Text] [Related]
11. Sickle cell disease vasculopathy: a state of nitric oxide resistance.
Wood KC; Hsu LL; Gladwin MT
Free Radic Biol Med; 2008 Apr; 44(8):1506-28. PubMed ID: 18261470
[TBL] [Abstract][Full Text] [Related]
12. Imaging hemoglobin oxygen saturation in sickle cell disease patients using noninvasive visible reflectance hyperspectral techniques: effects of nitric oxide.
Zuzak KJ; Gladwin MT; Cannon RO; Levin IW
Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1183-9. PubMed ID: 12791593
[TBL] [Abstract][Full Text] [Related]
13. Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysis.
Deonikar P; Kavdia M
J Appl Physiol (1985); 2012 Apr; 112(8):1383-92. PubMed ID: 22223452
[TBL] [Abstract][Full Text] [Related]
14. Role of Exercise-Induced Oxidative Stress in Sickle Cell Trait and Disease.
Chirico EN; Faës C; Connes P; Canet-Soulas E; Martin C; Pialoux V
Sports Med; 2016 May; 46(5):629-39. PubMed ID: 26666745
[TBL] [Abstract][Full Text] [Related]
15. Evolving treatment paradigms in sickle cell disease.
Jagadeeswaran R; Rivers A
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):440-446. PubMed ID: 29222291
[TBL] [Abstract][Full Text] [Related]
16. Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.
Kato GJ; Gladwin MT
JAMA; 2008 Dec; 300(22):2638-46. PubMed ID: 19066384
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin and nitric oxide.
Pawloski JR
N Engl J Med; 2003 Jul; 349(4):402-5; author reply 402-5. PubMed ID: 12879895
[No Abstract] [Full Text] [Related]
18. Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization.
Aslan M; Ryan TM; Townes TM; Coward L; Kirk MC; Barnes S; Alexander CB; Rosenfeld SS; Freeman BA
J Biol Chem; 2003 Feb; 278(6):4194-204. PubMed ID: 12401783
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological insights in sickle cell disease.
Odièvre MH; Verger E; Silva-Pinto AC; Elion J
Indian J Med Res; 2011 Oct; 134(4):532-7. PubMed ID: 22089617
[TBL] [Abstract][Full Text] [Related]
20. Impaired vasodilation by red blood cells in sickle cell disease.
Pawloski JR; Hess DT; Stamler JS
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2531-6. PubMed ID: 15699345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
